619 related articles for article (PubMed ID: 18848596)
1. Post-exposure prophylaxis (PEP) of rabies-infected Indian street dogs.
Manickama R; Basheer MD; Jayakumar R
Vaccine; 2008 Dec; 26(51):6564-8. PubMed ID: 18848596
[TBL] [Abstract][Full Text] [Related]
2. Immunogenicity and efficacy of an in-house developed cell-culture derived veterinarian rabies vaccine.
Kallel H; Diouani MF; Loukil H; Trabelsi K; Snoussi MA; Majoul S; Rourou S; Dellagi K
Vaccine; 2006 May; 24(22):4856-62. PubMed ID: 16600442
[TBL] [Abstract][Full Text] [Related]
3. Vaccine-induced rabies infection in rural dogs in Anambra State, Nigeria.
Okolo MI
Microbios; 1989; 57(231):105-12. PubMed ID: 2739582
[TBL] [Abstract][Full Text] [Related]
4. Development and evaluation of a competitive ELISA for estimation of rabies neutralizing antibodies after post-exposure rabies vaccination in humans.
Muhamuda K; Madhusudana SN; Ravi V
Int J Infect Dis; 2007 Sep; 11(5):441-5. PubMed ID: 17321182
[TBL] [Abstract][Full Text] [Related]
5. Comparison of antibody responses after vaccination with two inactivated rabies vaccines.
Minke JM; Bouvet J; Cliquet F; Wasniewski M; Guiot AL; Lemaitre L; Cariou C; Cozette V; Vergne L; Guigal PM
Vet Microbiol; 2009 Jan; 133(3):283-6. PubMed ID: 18757142
[TBL] [Abstract][Full Text] [Related]
6. Rabies post-exposure prophylaxis vaccination with purified chick embryo cell vaccine (PCECV) and purified Vero cell rabies vaccine (PVRV) in a four-site intradermal schedule (4-0-2-0-1-1): an immunogenic, cost-effective and practical regimen.
Ambrozaitis A; Laiskonis A; Balciuniene L; Banzhoff A; Malerczyk C
Vaccine; 2006 May; 24(19):4116-21. PubMed ID: 16545510
[TBL] [Abstract][Full Text] [Related]
7. Comparative evaluation of immunogenicity, reactogenecity and safety of purified chick embryo cell rabies vaccine and neural tissue rabies vaccine.
Deshpande AK; Londhe VA; Akarte S; Briggs D
J Assoc Physicians India; 2003 Jul; 51():655-8. PubMed ID: 14621031
[TBL] [Abstract][Full Text] [Related]
8. Field trials of a very potent rabies DNA vaccine which induced long lasting virus neutralizing antibodies and protection in dogs in experimental conditions.
Bahloul C; Taieb D; Diouani MF; Ahmed SB; Chtourou Y; B'chir BI; Kharmachi H; Dellagi K
Vaccine; 2006 Feb; 24(8):1063-72. PubMed ID: 16213633
[TBL] [Abstract][Full Text] [Related]
9. Vaccination of Tunisian dogs with the lyophilised SAG2 oral rabies vaccine incorporated into the DBL2 dog bait.
Hammami S; Schumacher C; Cliquet F; Tlatli A; Aubert A; Aubert M
Vet Res; 1999; 30(6):607-13. PubMed ID: 10596408
[TBL] [Abstract][Full Text] [Related]
10. Results of vaccination of Asian elephants (Elephas maximus) with monovalent inactivated rabies vaccine.
Isaza R; Davis RD; Moore SM; Briggs DJ
Am J Vet Res; 2006 Nov; 67(11):1934-6. PubMed ID: 17078758
[TBL] [Abstract][Full Text] [Related]
11. Multicenter comparative study of a new ELISA, PLATELIA RABIES II, for the detection and titration of anti-rabies glycoprotein antibodies and comparison with the rapid fluorescent focus inhibition test (RFFIT) on human samples from vaccinated and non-vaccinated people.
Feyssaguet M; Dacheux L; Audry L; Compoint A; Morize JL; Blanchard I; Bourhy H
Vaccine; 2007 Mar; 25(12):2244-51. PubMed ID: 17224214
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of inactivated tissue culture rabies vaccine in dogs.
Strating A; Bunn TO; Goff MT; Phillips CE
J Am Vet Med Assoc; 1975 Nov; 167(9):809-12. PubMed ID: 1237485
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of post-exposure vaccination against rabies in cattle.
Basheer AM; Ramakrishna J; Manickam R
New Microbiol; 1997 Jul; 20(3):289-94. PubMed ID: 9258949
[TBL] [Abstract][Full Text] [Related]
14. Factors influencing the antibody response to vaccination against rabies.
Jakel V; König M; Cussler K; Hanschmann K; Thiel HJ
Dev Biol (Basel); 2008; 131():431-7. PubMed ID: 18634505
[TBL] [Abstract][Full Text] [Related]
15. Three-year rabies duration of immunity in dogs following vaccination with a core combination vaccine against canine distemper virus, canine adenovirus type-1, canine parvovirus, and rabies virus.
Lakshmanan N; Gore TC; Duncan KL; Coyne MJ; Lum MA; Sterner FJ
Vet Ther; 2006; 7(3):223-31. PubMed ID: 17039445
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of the safety and immunogenicity of a new, heat-treated human rabies immune globulin using a sham, post-exposure prophylaxis of rabies.
Lang J; Gravenstein S; Briggs D; Miller B; Froeschle J; Dukes C; Le Mener V; Lutsch C
Biologicals; 1998 Mar; 26(1):7-15. PubMed ID: 9637744
[TBL] [Abstract][Full Text] [Related]
17. [Serologic response in dogs after a mass primary antirabies vaccination (inactivated vaccine) at Pikine Dakar (Senegal)].
Akakpo AJ; Mbou G; Bornarel P; Sarradin P; Bada Alambjedi R
Dakar Med; 1993; 38(2):123-8. PubMed ID: 7758368
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of a square presentation of V-RG vaccine baits in red fox, domestic dog and raccoon dog.
Cliquet F; Guiot AL; Schumacher C; Maki J; Cael N; Barrat J
Dev Biol (Basel); 2008; 131():257-64. PubMed ID: 18634487
[TBL] [Abstract][Full Text] [Related]
19. [Rabies in dogs and efficacy of active immunoprophylaxis in Yugoslavia].
Stankov S; Lalosević D; Pavlović R; Lalosević V; Knezević N; Budincević I
Med Pregl; 1998; 51 Suppl 1():43-6. PubMed ID: 9769655
[TBL] [Abstract][Full Text] [Related]
20. Protection of dogs against death from experimental rabies by postexposure administration of rabies vaccine and hyperimmune globulin (human).
Cho HC; Lawson KF
Can J Vet Res; 1989 Oct; 53(4):434-7. PubMed ID: 2590870
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
